Seres Therapeutics, Inc. (MCRB)
NGS · Common · CUSIP 81750R102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for MCRB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
81750R102
Market Cap
Mid Cap
IPO
6/25/2015 · $18.00/share
Previous Name
Seres Health, Inc.
Business: Seres Therapeutics, Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.

Company Contact

CEO
Richard Kender
CFO
Marella Thorell
Headquarters
101 Cambridgepark Drive, Cambridge, MA 02140
Phone
617-945-9626
Investor Relations
Robert Windsor · 617-203-3467 · rwindsor@serestherapeutics.com
General Email
info@serestherapeutics.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »